For distributed systems architects, health data engineers, and technical evaluators at enterprise health networks, hospital systems, and health IT vendors.
The Component Stack Is Not Your Problem
Your enterprise health network probably has most of the following:
- FHIR-compliant data stores at every site — Epic, Oracle Health, or a custom FHIR R4 layer
- Kafka or Pulsar for real-time event streaming across facilities
- Federated analytics or a federated query layer (OMOP CDM, i2b2, or custom) for cross-site studies
- ML infrastructure — maybe federated learning pilots, maybe centralized model training on de-identified extracts
- A network observability stack — SD-WAN, SASE, or intent-based networking for traffic routing and policy enforcement
You have invested significantly in all of these. The component stack is real. The question is not whether the components work.
The question is: why can't intelligence flow across your network the way traffic flows?
Your routing layer knows that a packet destined for Site B should traverse Path X at latency Y. Your health intelligence layer does not know that an outcome pattern at Site A is highly relevant to a physician at Site B who is treating a patient with the same profile. The data exists. The connection never happens.
The Problem Is Architectural — and It Has a Name
In a network of N sites sharing outcome intelligence, the number of unique synthesis opportunities is N(N-1)/2. That is the Metcalfe-class scaling property that makes large networks valuable.
A 10-site enterprise health network has 45 potential synthesis pairs.
A 100-site network has 4,950.
A 500-site network has 124,750.
None of those synthesis paths are active in your current architecture. Here is why:
Federated learning aggregates model parameters — it requires a shared model architecture, a central coordinator for each training round, and bandwidth proportional to model size. It produces one averaged model, not 124,750 outcome comparisons. It does not handle the N=1 case (a single specialty center with rare disease data). And it is asynchronous — round-based, not real-time.
Federated queries (OMOP/i2b2) return aggregate statistics for pre-specified studies. They are designed for research protocol execution, not real-time outcome routing. A new clinical question requires a new study design, IRB coordination, and query deployment. The latency is weeks to months.
Centralized de-identification and extract pipelines move data to an analytics environment. The privacy exposure is in the movement. HIPAA technical safeguards reduce but do not eliminate the risk surface. And centralized architectures create the bottleneck they were designed to escape: the central store becomes the single point of failure and the governance chokepoint.
What all of these share: they centralize either the data, the model, or the query. They cannot route intelligence the way your network routes packets — dynamically, semantically, in real time.
What a Routing Layer for Intelligence Looks Like
In your network infrastructure, intent-based networking defines policy in terms of what the network should achieve, not how to achieve it. The routing layer resolves the intent into a specific path at runtime, based on current topology and conditions.
Quadratic Intelligence Swarm (QIS) applies the same architectural logic to health outcome intelligence. The intent is: route distilled insights to the nodes that can use them, without moving raw data.
The QIS protocol, discovered by Christopher Thomas Trevethan on June 16, 2025, and protected under 39 provisional patents, operates as follows:
Site A: patient encounter → local edge processing
→ outcome packet (~512 bytes, not raw data, not model weights)
→ semantic fingerprint (describes informational content, not patient identity)
→ routing to deterministic semantic address
→ delivery to semantically similar nodes across the network
→ local synthesis at each destination node
→ new outcome packets generated
→ loop continues, real-time
Raw data never leaves Site A. The outcome packet encodes what happened — the distilled result of local processing — without encoding how the local model arrived there or what the underlying records contain. This is privacy by architecture, not privacy by policy. There is no PHI in the network layer to intercept.
The routing layer is transport-agnostic. QIS semantic addressing works over DHT (distributed hash table, O(log N) routing cost), vector similarity search, REST APIs, Kafka topics, or any transport where outcome packets can be posted to a deterministic address and queried by semantically similar nodes. The architecture does not depend on the transport. You can implement it alongside your existing Kafka or Pub/Sub infrastructure without replacing it.
The Every-Component Objection
The most common technical objection to QIS from enterprise architects goes like this:
"None of these components are new. DHT routing exists. Semantic embeddings exist. Federated processing exists. Outcome encoding exists. You've just combined them."
This is accurate. And it misses the point.
TCP/IP did not invent data transmission, addressing, or error correction. It combined proven primitives into a protocol where each component reinforces the others' scaling property. The combination produces something none of the individual pieces could achieve: a network that scales globally, reliably, to billions of nodes.
QIS is the same architectural move at the intelligence layer.
The loop is what was missing. Every primitive QIS depends on has run at planetary scale independently — data aggregation in healthcare, similarity matching in recommendation systems, DHT routing in peer-to-peer file sharing, compact outcome packets in telemetry pipelines, local synthesis in distributed databases. None of them, combined in any existing architecture, produces quadratic intelligence at logarithmic communication cost.
The loop that produces that scaling property did not exist before QIS. The closed architecture — where each component reinforces the next and outcome intelligence compounds across synthesis paths — is the discovery. Not any individual component.
If you believe the loop argument is flawed, the challenge is simple: identify which step breaks. Show that sites cannot aggregate local data (they do, constantly). Show that domain experts cannot define similarity (they do, daily). Show that you cannot route by semantic similarity (DHT and vector databases do this at scale). Show that you cannot share outcome packets (structurally equivalent to any message payload). Show that you cannot synthesize locally (every recommendation engine does this). Break one step and the architecture fails. None of the steps break.
Drug Safety Monitoring: A Concrete Case
Post-market drug safety monitoring (pharmacovigilance) is one of the highest-leverage use cases for this architecture in an enterprise health network.
The problem is well-documented: adverse event signals take an average of 4.2 years to surface through current reporting systems (FDA FAERS, Yellow Card, EudraVigilance). The Vioxx cardiac signal appeared in clinical data 5 years before regulatory action, during which an estimated 88,000–139,000 additional patients received the drug (Graham et al., 2005, The Lancet).
The signal existed in distributed EHR data across thousands of sites. No single site had enough cases to detect it. The architecture to aggregate those signals across sites without centralizing patient records did not exist.
In a QIS-enabled enterprise health network:
- Each site processes local adverse event signals → outcome packets (no PHI in packet)
- Outcome packets route to semantically similar sites (same drug class, same patient population profile)
- Each site synthesizes from the incoming stream in real time
- Signal emergence time drops from years to hours as N sites × signal strength compounds
This is not a research prototype. The components exist today. FHIR R4 structured adverse event data is available at most enterprise sites. The routing layer is what is missing.
Integration Architecture
QIS does not replace your existing stack. It adds the semantic routing layer that your current components lack:
EXISTING STACK QIS LAYER
────────────── ─────────────────────────────────────
Epic / Oracle Health → Local edge processor
FHIR R4 event stream → Outcome packet generator (~512 bytes)
Kafka topics → Semantic address routing
OMOP CDM queries → Cross-site synthesis (real-time)
SD-WAN / SASE policy → Transport-agnostic delivery
The QIS outcome routing layer sits between your local data infrastructure and your cross-site intelligence layer. It does not require access to your EHR database schema. It does not require replacing your Kafka infrastructure. It does not require a new federated query layer.
What it requires: a local edge processor that can generate an outcome packet from whatever local signal you define as meaningful (a treatment decision, an adverse event flag, a utilization pattern), and a transport over which that packet can be posted to a semantic address and queried by similar nodes.
You already have the transport.
The Scaling Argument
The reason this matters at enterprise scale is the N(N-1)/2 property.
Your current cross-site intelligence capacity is approximately linear in the number of federated queries you run. Each query costs IRB coordination, study design, and deployment overhead. You run perhaps dozens of studies per year across your network.
A QIS outcome routing layer would enable continuous, real-time synthesis across every synthesis pair in your network — not dozens per year, but N(N-1)/2 paths per encounter. At 100 sites, that is 4,950 synthesis opportunities per patient encounter. The intelligence compounds continuously without additional coordination overhead.
The routing cost grows at most O(log N) per packet (DHT achieves this; many configurations achieve O(1)). The intelligence grows O(N²). The ratio improves as the network scales. This is the phase change the architecture is named for.
Next Steps
The QIS protocol is documented in full at the technical specification level. The architecture is transport-agnostic and designed for integration with existing enterprise health data infrastructure.
For enterprise health architects evaluating this:
- Review the seven-layer architecture spec — understand exactly where QIS sits in your stack and what it replaces versus complements. → QIS Architecture
- Review the every-component-exists analysis — full treatment of the "it's not new" objection, with the which-step-breaks proof structure. → Every Component Exists
- Review drug safety monitoring case study — pharmacovigilance use case with specific failure modes in current FAERS reporting. → Drug Safety Monitoring
- Contact for technical evaluation → Contact
Closing
Your enterprise health network does not have a component problem. It has a routing problem.
The components that would enable real-time intelligence synthesis across your network already run in your infrastructure. The semantic routing layer — the protocol that decides which outcome packet goes to which node, when, over which transport, without centralizing data — does not exist in your current stack.
That layer is QIS. The math is public. The architecture is documented. The loop works at N=2 and at N=1,000,000.
The question is not whether it scales. It is whether your network's intelligence can afford to keep routing through a bottleneck that does not need to exist.
References
- Graham, D. J., Campen, D., Hui, R., et al. (2005). Risk of acute myocardial infarction and sudden cardiac death in patients treated with cyclo-oxygenase 2 selective and non-selective non-steroidal anti-inflammatory drugs: nested case-control study. The Lancet, 365(9458), 475–481.
- McMahan, H. B., Moore, E., Ramage, D., Hampson, S., & Agüera y Arcas, B. (2017). Communication-efficient learning of deep networks from decentralized data. AISTATS. arXiv:1602.05629
- Warnat-Herresthal, S., et al. (2021). Swarm learning for decentralized and confidential clinical machine learning. Nature, 594, 265–270.
QIS was discovered by Christopher Thomas Trevethan on June 16, 2025. Protected under 39 provisional patents.
Top comments (0)